Former FDA Chief Counsel Elizabeth Dickinson Hailed For Her Expertise, Warmth And Mentorship
Dickinson, who joined the Office of Chief Counsel in 1994, retired on 24 September. Former colleagues note the impact she had within and outside the agency, particularly as the ‘legendary leader’ of the legal approach to generic drugs.
You may also be interested in...
Rick Blumberg, FDA’s “Fearless And Passionate” Chief Litigation Counsel, Dies At 69
The food and drug law bar is mourning the passing of Blumberg, who joined FDA in 1970 where he became known as a tough, fair, candid champion of the agency.
FDA Looks Inside For Chief Counsel, Taps Elizabeth Dickinson
Former FDA attorneys laud her appointment, saying she is highly regarded inside and outside the agency for her intelligence, warmth and expertise on Hatch-Waxman and other key issues.
FDA Wrangles With Generic Exclusivity, Looks To Courts For Direction
For FDA, resolving 180-day exclusivity issues may be as difficult as Lisbeth Salander’s quest to figure out Fermat’s Last Theorem.